Clinical Trial Update: Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating esmolol infusion for patients with septic shock and persistent tachycardia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Septic Shock | Phase 2 | Status: COMPLETED | Results posted: 2019-01-09